eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Check drugs       Compare drugs       Join a support group

Vesicare vs Oxybutynin Chloride for a female patient aged 67

Summary: 2,285 female patients aged 67 (±5) who take the same drugs are studied.

This is personalized comparison of Vesicare vs Oxybutynin Chloride for a female aged 67. The study is created by eHealthMe based on reports from FDA and social media.

 

What are the drugs

Vesicare (latest outcomes from 7,648 users) has active ingredients of solifenacin succinate. It is often used in urge incontinence.

Oxybutynin chloride (latest outcomes from 2,874 users) has active ingredients of oxybutynin chloride. It is often used in urge incontinence.

On Mar, 27, 2015: 2,285 female patients aged 61 who take the same drugs are studied in Vesicare vs Oxybutynin Chloride

Information of patient in study:

GenderAgeReason for the drug
Female61Urinary frequency or urgency

Drugs to compare:

DrugIngredientsCompany
Vesicare solifenacin succinatenot specified
Oxybutynin Chloride oxybutynin chlorideUsl Pharma

eHealthMe real world results:

For females aged 61 (±5):

Most common side effects:

(click on each outcome to view in-depth analysis, incl. how people recovered)
VesicareOxybutynin Chloride (Usl Pharma)
Drug IneffectiveFall
ConstipationNausea
HeadacheAsthenia
Dry MouthOedema Peripheral
Vision BlurredDyspnoea
PainUrinary Tract Infection
FatigueDepression
DepressionAnxiety
Urinary Tract InfectionArthralgia
AnxietyHeadache

Most common side effects experienced by people in long term use:

(click on each outcome to view in-depth analysis, incl. how people recovered)
VesicareOxybutynin Chloride (Usl Pharma)
DiarrhoeaBladder Transitional Cell Carcinoma Stage Iii
IncontinenceBladder Cancer
Bowel ObstructionRespiratory Failure
Overactive BladderBreast Cancer
OedemaHair Loss
Diarrhoea
Abdominal Cramps
Lung Neoplasm Malignant
Renal Failure
Breast Cancer Female

Drug effectiveness:

not at allsomewhatmoderatehighvery high
Vesicare6.98%27.91%23.26%34.88%6.98%
Oxybutynin Chloride0.00%25.81%32.26%22.58%19.35%

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Next: study your drugs OR ask a question from Patients Like You

 

 

 

Drug effectiveness in real world:

Alternative drugs:

Side effects in real world:

On eHealthMe, Vesicare (solifenacin succinate) is often used to treat urge incontinence. Oxybutynin Chloride (oxybutynin chloride) is often used to treat urge incontinence. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

Recent related drug comparison:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.